Showing 2111-2120 of 4264 results for "".
Update: Oral Therapies for the Treatment of BCC
https://practicaldermatology.com/topics/practice-management/update-oral-therapies-for-the-treatment-of-bcc/21132/With the recent FDA approval of a new oral agent, the therapeutic outlook for BCC is both more diverse and promising.In Case of Emergency…
https://practicaldermatology.com/topics/practice-management/in-case-of-emergency/21155/Social Bullying: What's Our Role in It?
https://practicaldermatology.com/topics/practice-management/social-bullying-whats-our-role-in-it/21187/Mohs Certification: A Call for Dialogue
https://practicaldermatology.com/topics/practice-management/mohs-certification-a-call-for-dialogue/21222/New Products
https://practicaldermatology.com/columns/new-products/new-products/21262/Melanoma Treatment Landscape Evolves
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-treatment-landscape-evolves/21314/The first agent to target the PD-1 pathway, pembrolizumab may prolong life expectancy in some patients.Analyzing Risk Factors for Subsequent Primary Melanomas
https://practicaldermatology.com/topics/skin-cancer-photoprotection/analyzing-risk-factors-for-subsequent-primary-melanomas/21429/SPF Recommendations: Should They Change?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/spf-recommendations-should-they-change/21475/What is the minimum SPF dermatologists should be recommending to their patients?New Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21633/Hyperpigmentation in Darker Skin Types: A Review of Current Treatments
https://practicaldermatology.com/programs/practical-dermatology/hyperpigmentation-in-darker-skin-types-a-review-of-current-treatments/24217/Pigmentary disorders are a leading concern for patients and consumers worldwide.